Novel Targets for Detection of Cancer and Their Modulation by Chemopreventive Natural Compounds
Overview
Authors
Affiliations
Cancer affects the lives of millions of people. Several signaling pathways have been proposed as therapeutic targets for cancer therapy, and many more continue to be validated. With the identification and validation of therapeutic targets comes the question of designing novel strategies to effectively counter such targets. Natural compounds from dietary sources form the basis of many ancient medicinal systems. They are pleiotropic i.e. they act on multiple targets, and, therefore, are often the first agents to be tested against a novel therapeutic target. This review article summarizes the knowledge so far on some actively pursued targets - Notch, CXCR4, Wnt and sonic hedgehog (shh) pathways, the process of epithelial-mesenchymal transition (EMT) as well as molecular markers such as uPA-uPAR, survivin, FoxM1, and the microRNAs. We have performed an extensive survey of literature to list modulation of these targets by natural agents such as curcumin, indole-3-carbinol (I3C), 3,3'-diindolylmethane (DIM), resveratrol, epigallocatechin-3-gallate (EGCG), genistein etc. We believe that this review will stimulate further research for elucidating and appreciating the value of these wonderful gifts from nature.
Sax S, Centomo M, Centofanti F, Rizzacasa B, Cox S, Cox C Int J Mol Sci. 2024; 25(21).
PMID: 39519210 PMC: 11546363. DOI: 10.3390/ijms252111652.
Synthetic Methodologies and Therapeutic Potential of Indole-3-Carbinol (I3C) and Its Derivatives.
Centofanti F, Buono A, Verboni M, Tomino C, Lucarini S, Duranti A Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259386 PMC: 9960368. DOI: 10.3390/ph16020240.
Promising Strategy of mPTP Modulation in Cancer Therapy: An Emerging Progress and Future Insight.
Waseem M, Wang B Int J Mol Sci. 2023; 24(6).
PMID: 36982637 PMC: 10051994. DOI: 10.3390/ijms24065564.
Curcumin-Based Nanoformulations: A Promising Adjuvant towards Cancer Treatment.
Hafez Ghoran S, Calcaterra A, Abbasi M, Taktaz F, Nieselt K, Babaei E Molecules. 2022; 27(16).
PMID: 36014474 PMC: 9414608. DOI: 10.3390/molecules27165236.
Pouliquen D, Boissard A, Henry C, Coqueret O, Guette C Front Pharmacol. 2022; 13:934534.
PMID: 35873564 PMC: 9304619. DOI: 10.3389/fphar.2022.934534.